Koers Chongqing Lummy Pharmaceutical Co., Ltd.
Aandelen
300006
CNE100000H10
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,69 CNY | -0,37% | -0,74% | -27,69% |
Omzet 2022 | 885 mln. 122 mln. 114 mln. | Omzet 2023 | 896 mln. 124 mln. 116 mln. | Marktkapitalisatie | 3,93 mld. 542 mln. 507 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -68 mln. -9,39 mln. -8,78 mln. | Nettowinst (verlies) 2023 | -8 mln. -1,1 mln. -1,03 mln. | EV/omzet 2022 | 4 x |
Nettoliquiditeiten 2022 | 481 mln. 66,39 mln. 62,12 mln. | Nettoliquiditeiten 2023 | 566 mln. 78,07 mln. 73,05 mln. | EV/omzet 2023 | 3,75 x |
K/w-verhouding 2022 |
-58,5
x | K/w-verhouding 2023 |
-438
x | Werknemers | 800 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 32,5% |
1 dag | -0,37% | ||
1 week | -0,74% | ||
Lopende maand | -12,66% | ||
1 maand | -12,09% | ||
3 maanden | -17,23% | ||
6 maanden | -28,84% | ||
Lopend jaar | -27,69% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Rong Zhao Qiu
CEO | Chief Executive Officer | 30 | 12-06-20 |
Wen Lai
DFI | Director of Finance/CFO | 50 | 01-01-03 |
Yuan Yuan
CHM | Chairman | 42 | 01-02-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Xue Feng Leng
BRD | Director/Board Member | 52 | - |
Zhang Bi Li
BRD | Director/Board Member | 52 | 13-07-20 |
Hui Chuan Xu
CTO | Chief Tech/Sci/R&D Officer | 46 | 01-01-07 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 2,69 | -0,37% | 16 618 000 |
23-04-24 | 2,7 | +1,50% | 13 208 100 |
22-04-24 | 2,66 | +0,76% | 10 131 450 |
19-04-24 | 2,64 | -0,75% | 8 612 440 |
18-04-24 | 2,66 | -1,85% | 12 407 280 |
slotkoers Shenzhen S.E., 24 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-27,69% | 392 mln. | |
+22,85% | 562 mld. | |
-5,24% | 358 mld. | |
+16,49% | 322 mld. | |
+8,28% | 297 mld. | |
+12,36% | 219 mld. | |
+6,47% | 199 mld. | |
-10,06% | 196 mld. | |
-8,75% | 149 mld. | |
-5,21% | 146 mld. |